ainewsblitz.com

Breaking

UK Commission Calls for Lifecycle Rules as FDA Opens Debate on Medical AI

  • Policy & Regulation
  • Healthcare

The United Kingdom on Sept. 10 published recommendations for regulating artificial intelligence in healthcare, calling for oversight that follows AI-enabled medical devices from development and deployment through updates and real-world monitoring. The blueprint is advisory rather than final law, with a cross-government response expected separately.

Continue reading

The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.

$20
Read this article
$29/month
Unlimited — all 27,365 articles, the full archive, and comprehension quizzes
Save 72%
$98/year
≈ $8.17/month
Unlimited, billed once a year